PAI-1, a serine protease inhibitor and one of the most important coagulating agents providing balance against the fibrinolytic system, has been shown to have a significant effect on the increase in morbidly obese patients and the increase in thrombotic events in obesity [26]. This evidence concerns the gene SERPINE1 and obesity disorder.